AV
Anteris Tech
AVR.AX·ASXBrisbane AUFounded 201460 employees
Micro CapbiotechPublicCardiology
Platform: ADAPT TAVR
Market Cap
$0.15B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (AVR.AX)
Loading AVR.AX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| AVR-5957 | AVR-5957 | NDA/BLA | 1 | EZH2 | MDDMCC | ||
| Nirazumab | AVR-1263 | Phase 1 | 1 | BCL-2 | Angelman |
SEC Filings & Financial Documents
SEC filings are not available for ASX-listed companies.
Anteris Tech trades on ASX (AU). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)